ACE2 and chronic obstructive pulmonary disease: In comorbidities associated with severe and high-risk COVID-19 cases, such as COPD (Chronic obstructive pulmonary disease), smoking, air pollution [6], cardiovascular diseases (CVD), and type 2 diabetes (T2D), ACE2 levels are increased in the lungs, heart, and oral cavity.